Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| GEN | Hoskins Roche L Talbott | Director | 06.10.2026 | Zuteilung | 22,80 | 2.030 | 46.284 | Form 4 |
| GEN | Hoskins Roche L Talbott | Director | 06.10.2026 | Zuteilung | — | 10.966 | — | Form 4 |
| GENI | Castellani Bryan | Chief Financial Officer | 02.10.2026 | Steuer-Abgabe | 5,68 | 53.297 | 302.727 | Form 4 |
| GENI | Castellani Bryan | Chief Financial Officer | 02.10.2026 | Optionsausübung | — | 151.771 | — | Form 4 |
| GENI | Russell Thomas | Chief Legal Officer | 17.09.2026 | Verkauf | 6,51 | 50.000 | 325.565 | Form 4 |
| GENI | Locke Mark | Chief Executive Officer | 17.09.2026 | Verkauf | 6,54 | 50.000 | 327.050 | Form 4 |
| GENI | Locke Mark | Chief Executive Officer | 16.09.2026 | Verkauf | 6,56 | 272.551 | 1.789.243 | Form 4 |
| GENI | Locke Mark | Chief Executive Officer | 15.09.2026 | Verkauf | 6,58 | 477.449 | 3.139.275 | Form 4 |
| GEN | Vlcek Ondrej | Director | 09.09.2026 | Steuer-Abgabe | 29,76 | 2.647 | 78.775 | Form 4 |
| GEN | Vlcek Ondrej | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Smith Sherrese M | Director | 09.09.2026 | Zuteilung | — | 1.680 | — | Form 4 |
| GEN | Smith Sherrese M | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Heath Emily | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Denzel Nora | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Chrystal John C | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Brandt Eric | Director | 09.09.2026 | Schenkung | — | 8.822 | — | Form 4 |
| GEN | Brandt Eric | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Baudis Pavel | Director | 09.09.2026 | Steuer-Abgabe | 29,76 | 2.647 | 78.775 | Form 4 |
| GEN | Baudis Pavel | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Barsamian Sue | Director | 09.09.2026 | Schenkung | — | 8.822 | — | Form 4 |
| GEN | Barsamian Sue | Director | 09.09.2026 | Zuteilung | — | 9.072 | — | Form 4 |
| GEN | Ko Bryan Seuk | COO, CLO and Secretary | 04.09.2026 | Verkauf | 30,67 | 28.248 | 866.451 | Form 4 |
| GENB | Arnold Frances | Director | 01.09.2026 | Verkauf | 16,00 | 1.000 | 16.002 | Form 4 |
| GEN | Vlcek Ondrej | Director | 01.09.2026 | Steuer-Abgabe | 30,02 | 128 | 3.843 | Form 4 |
| GEN | Vlcek Ondrej | Director | 27.08.2026 | Verkauf | 30,00 | 200.000 | 6.000.000 | Form 4 |
| GEN | Vlcek Ondrej | Director | 25.08.2026 | Verkauf | 29,00 | 152.358 | 4.418.397 | Form 4 |
| GEN | Vlcek Ondrej | Director | 21.08.2026 | Verkauf | 29,00 | 47.462 | 1.376.407 | Form 4 |
| GEN | Vlcek Ondrej | Director | 19.08.2026 | Verkauf | 28,00 | 100.000 | 2.800.000 | Form 4 |
| GEN | Witteveen Travis Michael | Head of Products and Portfolio | 17.08.2026 | Verkauf | 28,06 | 440 | 12.346 | Form 4 |
| GEN | Witteveen Travis Michael | Head of Products and Portfolio | 15.08.2026 | Zuteilung | 24,21 | 440 | 10.652 | Form 4 |
| GEN | Witteveen Travis Michael | Head of Products and Portfolio | 10.08.2026 | Verkauf | 29,42 | 30.000 | 882.558 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).